Crossmark

Clinical value of biomarkers in relation to artery size in eosinophilic granulomatosis with polyangiitis: findings from an inception cohort at a Japanese City Hospital

Crossref DOI link: https://doi.org/10.1007/s10067-025-07634-2

Published Online: 2025-08-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oiwa, Hiroshi https://orcid.org/0000-0001-8924-8616
Yahata, Akihiro

Nakamoto, Naoki
License Information

Text and Data Mining valid from 2025-08-18

Version of Record valid from 2025-08-18
More Information

Article History

Received: 29 April 2025

Revised: 2 August 2025

Accepted: 6 August 2025

First Online: 18 August 2025

Declarations

:

: This study complied with the Declaration of Helsinki, and the institutional review board of Hiroshima City Hiroshima Citizens Hospital approved this study (approval no. 2024–122). The need to obtain informed consent from patients was waived in accordance with the regulations for retrospective cohort studies. Information for patients regarding this study was provided on the hospital website.

: HO has received lecture fees from GlaxoSmithKline and AstraZeneca. AY and NN declare no conflicts of interest.

Document is current

Any future updates will be listed below